Gerrit Johan Schefferlie

At its May 2022 meeting, the European Medicines Agency’s (EMA) Committee for Veterinary Medicinal Products (CVMP) elected Gerrit Johan Schefferlie from the Netherlands as its new Chair for the next three years.

He takes over the role from David Murphy from the Health Products Regulatory Authority (HPRA) in Ireland who has completed the maximum of two 3-year mandates as Chair since 2016.

’’I am looking forward to leading the Committee in delivering on its objectives and to contribute to the goals of the new Veterinary Medicinal Products Regulation (Regulation (EU) 2019/6) in terms of increasing availability of veterinary medicines and decreasing the administrative burden,” said Schefferlie.

’’The CVMP will continue to provide advice to the European Commission as well as develop regulatory guidance on many aspects of interpretation and implementation of the new Regulation. We have an ambitious workplan with specific objectives in the areas of antimicrobial resistance, vaccine availability, novel therapies, consumer safety, and environmental safety, just to name a few.’’

Schefferlie has been a member of the CVMP since 2007 and its Vice-chair since July 2019. He is a biologist by training and has been a Senior Regulatory Project Leader at the Dutch Medicines Evaluation Board since 2007. With extensive experience in toxicological and consumer risk assessment of residues of veterinary drugs in food of animal origin, he has collaborated as an expert for the International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products (VICH), the European Food Safety Authority (EFSA) and the Joint WHO/FAO Expert Committee on Food Additives (JECFA), co-authoring several reports.

The CVMP plays a vital role for animal and public health in ensuring the availability of good quality, safe and effective medicines for veterinary use.

The CVMP will elect a new Vice-chair at its June 2022 meeting.

Share this page